Oncology Institute (TOI) Equity Ratio (2019 - 2026)

Oncology Institute has reported Equity Ratio for 8 years, with the latest figure at 0.1 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 413.19% year-over-year to 0.1; the trailing twelve-month figure through Mar 2026 stood at 0.1 (down 413.19% YoY), and the FY2025 full-year result was 0.1, down 559.45% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.1, down from 0.1 in the prior quarter.
• The five-year high for Equity Ratio was 0.65 in Q2 2022, with the low at 0.1 in Q1 2026.
• Historically, Equity Ratio has averaged 0.22 across 5 years, with a median of 0.2 in 2024.
• Annual changes were most pronounced in 2022 — Equity Ratio surged 213.23% — and 2025, when it tumbled 559.45%.
• Oncology Institute's Equity Ratio stood at 0.47 in 2022, then tumbled by 42.1% to 0.27 in 2023, then slumped by 92.38% to 0.02 in 2024, then sank by 559.45% to 0.1 in 2025, then dropped by 1.39% to 0.1 in 2026.
• The last three Equity Ratio figures came in at 0.1 (Q1 2026), 0.1 (Q4 2025), and 0.08 (Q3 2025), per Business Quant data.